Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18829513 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel, PSK®;   Drug: Docetaxel, Placebo
2 Recruiting Cultured Circulating Tumor Cells in Prostate and Other Cancers
Condition: Prostate Cancer
Intervention:

Study has passed its completion date and status has not been verified in more than two years.